We have the ability to produce vaccines. That work that you're describing has been done in Canada. All of the manufacturing processes, the supply chain, and everything we need to start producing mRNA vaccines in Canada are in place. The only thing that's missing is the capital for us to secure the raw materials and commit to the plant times.
We've put a budget forward to the strategic innovation fund that would accommodate for the clinical trial material, but they've clearly communicated to us that their mandate is strictly on clinical trial and that it does not encompass scale-up for commercial activity.
I've reached out and asked if they would put me in touch with.... I spoke to the finance committee. I'm speaking to this committee. Quite frankly, I'm not that familiar with who makes that decision in government. Maybe it's Minister Anand at Public Services and Procurement Canada.
If I had an order.... I'm not looking for a handout. I'll take an interest-free loan; I'll take a deposit on an order. I don't care how it comes. I just need the capital so that we can start the process.